Trials / Completed
CompletedNCT02637050
A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries
EMEA CTEPH Registry: An International Prospective Registry Investigating the Epidemiology, Diagnosis and Treatment of CTEPH Patients in EMEA Countries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 231 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the registry is the assessment of the diagnosis and treatment of CTEPH (Chronic Thromboembolic Pulmonary Hypertension) in EMEA (Europe/Middle East/Africa) countries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard of care | At the discretion of the attending physician. |
Timeline
- Start date
- 2016-03-03
- Primary completion
- 2020-07-03
- Completion
- 2020-09-17
- First posted
- 2015-12-22
- Last updated
- 2021-08-25
Locations
6 sites across 6 countries: Kazakhstan, Kyrgyzstan, Lebanon, Russia, Saudi Arabia, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02637050. Inclusion in this directory is not an endorsement.